MountainView Hospital Launches Minimally Invasive Robotic-Assisted Lung Biopsy Procedure
MountainView Hospital has launched a new procedure to aid in the detection of lung cancer with the use of the ION robotic-assisted bronchoscopy platform. This minimally invasive procedure extends the reach of the bronchoscope deep into all 18 segments of the lungs – often difficult in traditional bronchoscopy – in order to sample and detect lung cancer sooner.

The new procedure compliments MountainView Hospital’s Incidental Lung Nodule Detection program. Through this program, the hospital is using innovative technology to detect suspicious lung nodules by analyzing CT exams that were performed as part of routine care, for the presence of incidental lung nodules which could represent a malignancy. Nurse navigators then reach out personally to patients to ensure continued follow up care, and treatment if needed.

Additionally, as part of the multidisciplinary platform focused on early-stage cancer detection, MountainView Hospital offers a Low Dose CT Lung Screen Program for proactive identification and treatment of at-risk patients.

Robotic-assisted bronchoscopy uses an ultra-thin catheter and integrated vision probe that provides the physician direct vision to reach all parts of the lung. The catheter can move 180 degrees in all directions and the biopsy needle is flexible. Additionally, shape-sensing technology provides precise location and shape information throughout the whole biopsy process.

A lung biopsy is normally done when a small mass or nodule is discovered. A physician will often monitor the nodule, although sometimes a lung biopsy is ordered when it is a suspicious nodule. Biopsy involves obtaining a tissue sample from the suspicious area and examining the cells under a microscope to determine if cancer or another disease is present.

Dr. Vishisht Mehta of Comprehensive Cancer Centers of Nevada (CCCN) was the first physician to use the new robotic device at MountainView for patient biopsies. Dr. Sapna Bhatia and Dr. George Tu of CCCN also perform robotic-assisted bronchoscopic lung biopsies at MountainView Hospital. Dr. Arnold Chung, cardiovascular and thoracic surgeon with MountainView Cardiovascular Surgery also will utilize the robotic device for biopsies.

“Being able to offer a new approach for lung biopsies is an important part of detecting lung cancer early allowing better outcomes for patients,” said Julie Taylor, MountainView Hospital chief executive officer. “We hope this, combined with our lung nodule biopsy detection program and our low-dose CT screenings will positively impact lung cancer survival rates in our community.”

Caption: Dr. Vishisht Mehta uses the robot to conduct a robotic-assisted bronchoscopic lung biopsy.

Tahoe Forest Health System Receives the Best Places to Work Award for a Third Year in a Row
Tahoe Forest Health System is proud to be awarded 3rd place for the 2021 Greater Reno-Tahoe Best Places to Work in the Extra-Large Business category. The recognition took place at the 14th Annual Greater Reno-Tahoe Best Places to Work celebration, presented by the Northern Nevada Human Resources Association, held on Friday, August 27, 2021, at the Atlantis Casino Resort Spa in Reno.

“We are honored to be receiving this recognition among organizations across all industries for a third year in a row” says Harry Weis, President and CEO of Tahoe Forest Health System. “The Best Places to Work Award reflects our commitment to the community we serve as we continually strive to provide high quality healthcare delivery every day,” Weis added.

Best Places to Work winners are determined entirely on the basis of employees’ responses to the Employee Engagement Survey that measures key areas that make up an organization’s culture, including trust in leadership and employee engagement.

Tahoe Forest Health System provides an array of medical services reaching the communities of Truckee, North Lake Tahoe, Donner Summit, the Sierra Valley in California and Incline Village in Nevada.